Stockscreener 앱 받기
2.09
0.00%
0.00
시간 외 거래:
2.09
전일 마감가:
$2.09
열려 있는:
$2.08
하루 거래량:
55,884
Relative Volume:
0.20
시가총액:
$36.21M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
-0.48%
1개월 성능:
+0.48%
6개월 성능:
-20.83%
1년 성능:
-39.60%
1일 변동 폭
$2.08
$2.09
1주일 범위
$2.08
$2.10
52주 변동 폭
$0.95
$4.74
Mural Oncology Plc Stock (MURA) Company Profile
명칭
Mural Oncology Plc
전화
353 1 905 8020
주소
10 EARLSFORT TERRACE, DUBLIN 2
MURA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
MURA
Mural Oncology Plc
|
2.09 | 36.21M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Mural Oncology Plc Stock (MURA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-03-25 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2025-03-25 | 다운그레이드 | Raymond James | Strong Buy → Outperform |
| 2024-06-28 | 개시 | Rodman & Renshaw | Buy |
| 2024-04-04 | 개시 | Morgan Stanley | Overweight |
Mural Oncology Plc 주식(MURA)의 최신 뉴스
BlackRock discloses 1.64% stake in Mural Oncology - Investing.com
Citadel Group discloses 1.11% stake in Mural Oncology - Investing.com
BlackRock discloses 1.64% stake in Mural Oncology By Investing.com - Investing.com UK
How Mural Oncology plc stock performs during Fed tightening cyclesEarnings Performance Report & Growth Focused Stock Reports - newser.com
Combining price and volume data for Mural Oncology plcJuly 2025 Market Mood & Real-Time Buy Signal Notifications - newser.com
Is Mural Oncology plc a candidate for recovery play2025 Market Trends & Technical Confirmation Trade Alerts - newser.com
Is Mural Oncology plc stock ready for a breakoutJuly 2025 Snapshot & Risk Controlled Daily Trade Plans - newser.com
Mural Oncology shareholders approve acquisition by XRA 5 Corp. - MSN
What candlestick patterns are forming on Mural Oncology plc2025 Support & Resistance & Long-Term Growth Stock Strategies - newser.com
Exit strategy if you’re trapped in Mural Oncology plcJuly 2025 Summary & Weekly Stock Performance Updates - newser.com
Is Mural Oncology plc stock attractive for growth ETFsDollar Strength & Free Real-Time Market Sentiment Alerts - newser.com
REGCitadel Group Mural Oncology PLCForm 8.3Mural Oncology plc - TradingView
Will Mural Oncology plc stock maintain dividend yieldMarket Risk Report & Smart Allocation Stock Tips - newser.com
Can trapped investors hope for a rebound in Mural Oncology plc2025 Historical Comparison & Fast Gain Stock Trading Tips - newser.com
Published on: 2025-10-31 04:17:55 - newser.com
Why Mural Oncology plc stock is favored by pension funds2025 Trading Recap & Verified Swing Trading Watchlists - newser.com
Mural Oncology plc (MURA) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
Mural Oncology plc (MURA) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
Form 8.3The Vanguard Group, Inc.: Mural Oncology plc - TradingView
Why AXIL stock could see breakout soonTrade Risk Summary & Weekly Top Gainers Trade List - newser.com
Chart overlay techniques for tracking Mural Oncology plcTrade Volume Report & Daily Technical Stock Forecast Reports - newser.com
Citadel Group discloses 1.08% stake in Mural Oncology By Investing.com - Investing.com Australia
Can Mural Oncology plc stock resist sector downturnsMarket Weekly Review & Risk Controlled Swing Alerts - fcp.pa.gov.br
Citadel Group discloses 1.08% stake in Mural Oncology - Investing.com
Citadel Group discloses 0.99% stake in Mural Oncology By Investing.com - Investing.com Australia
Will Mural Oncology plc stock benefit from commodity pricesQuarterly Trade Report & Short-Term High Return Ideas - fcp.pa.gov.br
Why Mural Oncology plc stock could rally in 2025Analyst Upgrade & Accurate Entry/Exit Alerts - Fundação Cultural do Pará
Will Mural Oncology plc stock attract more institutional investorsPrice Action & Capital Efficiency Focused Ideas - fcp.pa.gov.br
Mural Oncology Plc Announces Acquisition by XOMA Royalty Corporation - MSN
Mural Oncology Plc (MURA) 재무 분석
Mural Oncology Plc (MURA)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
0.64%
0.35%
자본화:
|
볼륨(24시간):